chartexchange

EVLO
EVELO BIOSCIENCES INC
stockOTC

EODNov 19, 2026
0.0002USD+100.000%(+0.0001)5,000
Loading…
Loading…
Healthcare
Biotechnology
HQ
Cambridge, MA, USA
Previous Close
$0.00
Beta
-1250.59
52-Week High
$0.00 2026-03-03
52-Week Low
$0.00 2026-09-02
SMA 50
$0.00
SMA 200
$0.00
Avg. Vol 10D
17,634
Avg. Vol 30D
7,348
Avg. Vol 90D
6,007
Relative Vol
0.68
18.90M
Jun 30, 2023 · 1-for-20 (reverse)
Oct 1, 2026
EVLO Profile

evelo biosciences is dedicated to improving the lives of patients globally through the development of a new modality of medicines – monoclonal microbials. monoclonal microbials are orally delivered medicines that modulate systemic immunology and biology through direct interactions with human cells in the gut. these new medicines are broadly applicable across many diseases – including autoimmune, immunoinflammatory, metabolic, neurological, neuroinflammatory diseases and cancer. monoclonal microbials have the potential to fundamentally change traditional models of drug discovery and development. by finding and selecting naturally occurring monoclonal microbials with defined therapeutic effects, evelo can improve the speed, cost and success of drug discovery and development. evelo's platform enables pharmacological intervention at all stages of disease with naturally occurring, safe and effective monoclonal microbials. evelo biosciences was conceived and created within venturelabs®, flag

EVLO Performance
PeriodPriceDateChangeBeta
1M0.002026-10-21+100.00%0.000
3M0.002026-08-17+19900.00%475.520
6M0.002026-05-27+19900.00%-759.448
1Y0.002025-11-20-60.00%-1250.591
2Y0.002024-11-21-60.00%—
5Y179.202021-11-22-100.00%-125.245
EVLO Stock Summary

EVELO BIOSCIENCES INC (OTC:EVLO) stock price today is $0.00, and today's volume is 5,000. EVLO is up 100.000% today. The 30 day average volume is 7,348. EVLO market cap is $3,797 with 18.98M shares outstanding.